Viewing Study NCT01619332


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
Study NCT ID: NCT01619332
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2012-06-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module